CASE REPORT |
|
Year : 2017 | Volume
: 1
| Issue : 3 | Page : 77-82 |
|
Anaesthesia for ECT in neuroleptic malignant syndrome - what is ideal?
Priyaneka Baskaran, Jaishree Santhirasegaran, Norhuzaimah Bt Julai @ Julaihi
Miri General Hospital, Sarawak, Malaysia
Correspondence Address:
Jaishree Santhirasegaran Santhirasegaran, Anesthesiology and Intensive Care Unit (ICU), Hospital Miri, Jalan Cahaya, 98000, Miri, Sarawak Malaysia
 Source of Support: None, Conflict of Interest: None
DOI: 10.15562/bjoa.v1i3.41
|
|
We report a case involving a 46 year old male with schizophrenia who presented with fever, inability to speak, sialorrhoea, limb stiffness, profuse sweating, tremors and rigidity of bilateral upper and lower limbsfollowing an increase in dosage of his antipsychotics. A provisional diagnosis of neuroleptic malignant syndrome (NMS) was made based on the Levensen criteria. His antipsychotics were promptly discontinued and he was transferred to ICU for critical care support. We utilised lorazepam and prescribed bromocriptine and his NMS symptoms improved. However, in view of residual catatonic symptoms, decision was made to commence ECT. A combination of rocuronium sugammadex was used successfully in all his ECT procedures and found to be an excellent alternative to succinycholine in this patient.
|
|
|
|
[PDF]* |
|
 |
|